Opko Health (OPK) Return on Capital Employed (2011 - 2026)
Opko Health's (OPK) quarterly Return on Capital Employed came in at 2.85% in Q2 2026, up 1733.0% YoY from 0.16% in Q2 2025, and up 50.88% on a QoQ basis from 5.8% in Q1 2026.
Opko Health (OPK) Return on Capital Employed (2011 - 2026) Analysis & Trends
Opko Health (OPK) has 15 years of Return on Capital Employed data on file, last reported at 2.85% in Q2 2026.
- Quarterly Return on Capital Employed rose 1733.0% year-over-year to 2.85% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 2.85% (up 1733.0% YoY) and the FY2025 annual result came in at 6.12%, up 190.0% from the prior year.
- Return on Capital Employed grew to 2.85% in Q2 2026, from 5.8% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 2.85% in Q2 2026 to a low of 20.91% in Q1 2025.
- A 5-year average of 10.87% and a median of 9.48% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 1767 bps — and 2026, when it jumped 1733 bps.
- Tracing OPK's Return on Capital Employed over 5 years: stood at 11.41% in 2022, then gained by 25 bps to 8.56% in 2023, then plunged by 141 bps to 20.59% in 2024, then jumped by 69 bps to 6.46% in 2025, then jumped by 56 bps to 2.85% in 2026.
- The last three Return on Capital Employed figures came in at 2.85% (Q2 2026), 5.8% (Q1 2026), and 6.46% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.85% |
| 10 | Opko Health | 1.02 Bn | 718.85 Mn | 80.02 Mn | -2.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.85% |
| Mar 31, 2026 | -5.80% |
| Dec 31, 2025 | -6.46% |
| Sep 30, 2025 | -10.91% |
| Jun 30, 2025 | -20.18% |
| Mar 31, 2025 | -20.91% |
| Sep 30, 2024 | -20.59% |
| Jun 30, 2024 | -19.24% |
| Mar 31, 2024 | -11.07% |
| Dec 31, 2023 | -8.56% |
| Sep 30, 2023 | -7.51% |
| Jun 30, 2023 | -8.60% |
| Mar 31, 2023 | -9.48% |
| Dec 31, 2022 | -11.41% |
| Sep 30, 2022 | -11.53% |
| Jun 30, 2022 | -5.11% |
| Mar 31, 2022 | -4.51% |
| Dec 31, 2021 | 0.90% |
| Sep 30, 2021 | 6.14% |
| Jun 30, 2021 | 5.32% |